CRS To Congress: Consider Clarifying Drug Negotiation Judicial Review

Courts will be forced to interpret ambiguities in Congress’ landmark drug -pricing law when faced with all-but-certain drug industry suits challenging Medicare drug price negotiation, and lawmakers could avert unnecessary litigation by clarifying “which sections of the statute are judicially reviewable,” the nonpartisan the Congressional Research Service says in a recent report. In the report published May 16 , the office writes that there is an open question regarding the extent to which the new drug negotiation program is subject...